Transfusion-transmissible infections and transfusion-related immunomodulation

Best Practice and Research: Clinical Anaesthesiology

Volumn 22, Issue 3, 2008, Pages 503-517

  Buddeberg, Felix ^a   Schimmer, Beatrice Beck ^a   Spahn, Donat R ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

immunomodulation; infection; transfusion

Indexed keywords

ALLOIMMUNIZATION; BACTERIAL TRANSMISSION; BACTERIUM CONTAMINATION; BLOOD DONOR; BLOOD STORAGE; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; CANCER RECURRENCE; CLINICAL TRIAL; CYTOTOXIC T LYMPHOCYTE; DISEASE TRANSMISSION; ERYTHROCYTE TRANSFUSION; GRAFT SURVIVAL; HEART SURGERY; HLA MATCHING; HOSPITAL INFECTION; HUMAN; IMMUNE DEFICIENCY; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOPATHOGENESIS; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INFECTION CONTROL; INFECTION RISK; KIDNEY TRANSPLANTATION; LEUKOCYTE; MORBIDITY; MORTALITY; NATURAL KILLER CELL; NEUTROPHIL; NONHUMAN; PARASITE TRANSMISSION; PATHOPHYSIOLOGY; PATIENT SAFETY; POSTOPERATIVE INFECTION; PRION; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; STANDARDIZATION; TRANSFUSION ASSOCIATED GRAFT VERSUS HOST DISEASE; TRANSFUSION RELATED ACUTE LUNG INJURY; TRANSFUSION TRANSMISSIBLE INFECTION; VIRUS TRANSMISSION;

BLOOD TRANSFUSION; CROSS INFECTION; HUMANS; IMMUNOLOGIC FACTORS; POSTOPERATIVE COMPLICATIONS;

EID: 49349140741     PISSN: 15216896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpa.2008.05.003     Document Type: Review

References (86)

1. Cane R. Hemoglobin: how much is enough?. Critical Care Medicine 18 (1990) 1046-1047
2. Madjdpour C., Spahn D.R., and Weiskopf R.B. Anemia and perioperative red blood cell transfusion: a matter of tolerance. Critical Care Medicine 34 5 Suppl (2006) 102-108
3. Consensus conference. Platelet transfusion therapy. JAMA 257 13 (1987) 1777-1780
4. Consensus conference. Fresh-frozen plasma. Indications and risks. JAMA 253 4 (1985) 551-553
5. Madjdpour C., and Spahn D.R. Allogeneic red blood cell transfusions: efficacy, risks, alternatives and indications. British Journal of Anaesthesia 95 1 (2005) 33-42
6. Hébert P.C., Wells G., Blajchman M.A., et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. The New England Journal of Medicine 340 6 (1999) 409-417
7. Gould S., Cimino M.J., and Gerber D.R. Packed red blood cell transfusion in the intensive care unit: limitations and consequences. American Journal of Critical Care 16 1 (2007) 39-49
8. Group SHoTS. Serious hazards of transfusion. Available from:.
9. Davies A., Staves J., Kay J., et al. End-to-end electronic control of the hospital transfusion process to increase the safety of blood transfusion: strengths and weaknesses. Transfusion 46 3 (2006) 352-364
10. Dzik W.H. New technology for transfusion safety. British Journal of Haematology 136 2 (2007) 181-190
11. Busch M., Kleinman S., and Nemo G. Current and emerging infectious risks of blood transfusions. JAMA 289 8 (2003) 959-962
12. Cervia J., Wenz B., and Ortolano G. Leukocyte reduction's role in the attenuation of infection risks among transfusion recipients. Clinical Infectious Diseases 45 8 (2007) 1008-1013
13. Pealer L., Marfin A., Petersen L., et al. Transmission of West Nile virus through blood transfusion in the United States in 2002. The New England Journal of Medicine 349 13 (2003) 1236-1245
14. Wang J., Lee C., Kao J., et al. Incidence and clinical presentation of posttransfusion TT virus infection in prospectively followed transfusion recipients: emphasis on its relevance to hepatitis. Transfusion 40 5 (2000) 596-601
15. Umemura T., Yeo A., Sottini A., et al. SEN virus infection and its relationship to transfusion-associated hepatitis. Hepatology 33 5 (2001) 1303-1311
16. Kühn J. Transfusion-Associated Infections with Cytomegalovirus and Other Human Herpesviruses. Infusionstherapie und Transfusionsmedizin 27 3 (2000) 138-143
17. Ronghe M., Foot A.B., Cornish J., et al. The impact of transfusion of leucodepleted platelet concentrates on cytomegalovirus disease after allogeneic stem cell transplantation. British Journal of Haematology 118 4 (2002) 1124-1127
18. Bowden R., Slichter S.J., Sayers M., et al. A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion-associated CMV infection after marrow transplant. Blood 86 9 (1995) 3598-3603
19. Alfieri C., Tanner J., Carpentier L., et al. Epstein-Barr virus transmission from a blood donor to an organ transplant recipient with recovery of the same virus strain from the recipient's blood and oropharynx. Blood 87 2 (1996) 812-817
20. Wagner H., Klüter H., Kruse A., et al. Relevance of transmission of Epstein-Barr virus through blood transfusion. Beiträge zur Infusionstherapie und Transfusionsmedizin 32 (1994) 138-141
21. MacLennan S., and Williamson L.M. Risks of fresh frozen plasma and platelets. The Journal of Trauma 60 6 Suppl (2006) S46-S50
22. Chamberland M., Alter H., Busch M., et al. Emerging infectious disease issues in blood safety. Emerging Infectious Diseases 7 3 Suppl (2001) 552-553
23. O'Brien S., Yi Q., Fan W., et al. Current incidence and estimated residual risk of transfusion-transmitted infections in donations made to Canadian Blood Services. Transfusion 47 2 (2007) 316-325
24. Parsyan A., and Candotti D. Human erythrovirus B19 and blood transfusion - an update. Transfusion Medicine (Oxford, London) 17 4 (2007) 263-278
25. Hillyer C., Josephson C., Blajchman M., et al. Bacterial contamination of blood components: risks, strategies, and regulation: joint ASH and AABB educational session in transfusion medicine. Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program (2003) 575-589
26. Blajchman M., Beckers E., Dickmeiss E., et al. Bacterial detection of platelets: current problems and possible resolutions. Transfusion Medicine Reviews 19 4 (2005) 259-272
27. Kuehnert M., Roth V., Haley N., et al. Transfusion-transmitted bacterial infection in the United States, 1998 through 2000. Transfusion 41 12 (2001) 1493-1499
28. Rao P.L., Strausbaugh L.J., Liedtke L.A., et al. Bacterial infections associated with blood transfusion: experience and perspective of infectious diseases consultants. Transfusion 47 7 (2007) 1206-1211
29. Fang C., Chambers L.A., Kennedy J., et al. Detection of bacterial contamination in apheresis platelet products: American Red Cross experience, 2004. Transfusion 45 12 (2005) 1845-1852
30. Kitchen A., and Chiodini P. Malaria and blood transfusion. Vox Sanguinis 90 2 (2006) 77-84
31. Nelson J., Kauffmann D., Ciavarella D., et al. Acquired toxoplasmic retinochoroiditis after platelet transfusions. Annals of Ophthalmology 21 7 (1989) 253-254
32. Cardo L., Salata J., Harman R., et al. Leukodepletion filters reduce Leishmania in blood products when used at collection or at the bedside. Transfusion 46 6 (2006) 896-902
33. Cardo L., and Asher L. Transfusion medicine illustrated. Electron micrographic study of the removal of Trypanosoma cruzi from blood products by leukodepletion filters. Transfusion 46 7 (2006) 1067-1068
34. Llewelyn C., Hewitt P., Knight R., et al. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 363 9407 (2004) 417-421
35. Peden A., Head M., Ritchie D., et al. Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet 364 9433 (2004) 527-529
36. Wroe S., Pal S., Siddique D., et al. Clinical presentation and pre-mortem diagnosis of variant Creutzfeldt-Jakob disease associated with blood transfusion: a case report. Lancet 368 9552 (2006) 2061-2067
37. team E. Fourth case of transfusion-associated vCJD infection in the United Kingdom. Euro Surveillance 12 1 (2007) E070118.4
38. Burnouf T., and Padilla A. Current strategies to prevent transmission of prions by human plasma derivatives. Transfusion Clinique et Biologique 13 5 (2006) 320-328
39. Opelz G., Sengar D., Mickey M., et al. Effect of blood transfusions on subsequent kidney transplants. Transplantation Proceedings 5 1 (1973) 253-259
40. Gantt C. Red blood cells for cancer patients. Lancet 2 8242 (1981) 363
41. Busch O., Hop W., Hoynck van Papendrecht M., et al. Blood transfusions and prognosis in colorectal cancer. The New England Journal of Medicine 328 19 (1993) 1372-1376
42. Taylor R.W., Manganaro L., O'Brien J., et al. Impact of allogenic packed red blood cell transfusion on nosocomial infection rates in the critically ill patient. Critical Care Medicine 30 10 (2002) 2249-2254
43. Roelen D., van Rood J., Brand A., et al. Immunomodulation by blood transfusions. Vox Sanguinis 78 2 Suppl (2000) 273-275
44. (TRAP) TtRAtPSG. Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions. The Trial to Reduce Alloimmunization to Platelets Study Group. The New England Journal of Medicine 337 26 (1997) 1861-1869
45. Andreu G., and Dewailly J. Prevention of HLA alloimmunization by using leukocyte-depleted components. Current Studies In Hematology and Blood Transfusion 60 (1994) 29-40
46. Naji A. Induction of tolerance by intrathymic inoculation of alloantigen. Current Opinion in Immunology 8 5 (1996) 704-709
47. Mowbray J., Gibbings C., Liddell H., et al. Controlled trial of treatment of recurrent spontaneous abortion by immunisation with paternal cells. Lancet 1 8435 (1985) 941-943
48. Rothstein D., and Sayegh M. T-cell costimulatory pathways in allograft rejection and tolerance. Immunological Reviews 196 (2003) 85-108
49. Mincheff M., and Meryman H. Costimulatory signals necessary for induction of T cell proliferation. Transplantation 49 4 (1990) 768-772
50. Brand A. Immunological aspects of blood transfusions. Blood Reviews 14 3 (2000) 130-144
51. Sho M., Sandner S., Najafian N., et al. New insights into the interactions between T-cell costimulatory blockade and conventional immunosuppressive drugs. Annals of Surgery 236 5 (2002) 667-675
52. Dzik W.H. Mononuclear cell microchimerism and the immunomodulatory effect of transfusion. Transfusion 34 11 (1994) 1007-1012
53. Gafter U., Kalechman Y., and Sredni B. Blood transfusion enhances production of T-helper-2 cytokines and transforming growth factor beta in humans. Clinical Science (London) 91 4 (1996) 519-523
54. Peters W., Fry R., Fleshman J., et al. Multiple blood transfusions reduce the recurrence rate of Crohn's disease. Diseases of the Colon and Rectum 32 9 (1989) 749-753
55. Lee T., Paglieroni T., Utter G., et al. High-level long-term white blood cell microchimerism after transfusion of leukoreduced blood components to patients resuscitated after severe traumatic injury. Transfusion 45 8 (2005) 1280-1290
56. Utter G.H., Nathens A.B., Lee T.-H., et al. Leukoreduction of blood transfusions does not diminish transfusion-associated microchimerism in trauma patients. Transfusion 46 11 (2006) 1863-1869
57. Reed W., Lee T., Norris P., et al. Transfusion-associated microchimerism: a new complication of blood transfusions in severely injured patients. Seminars in Hematology 44 1 (2007) 24-33
58. Brand A. Immunological aspects of blood transfusions. Transplant Immunology 10 2-3 (2002) 183-190
59. Nielsen H., Reimert C., Pedersen A., et al. Time-dependent, spontaneous release of white cell- and platelet-derived bioactive substances from stored human blood. Transfusion 36 11-12 (1996) 960-965
60. Bury T., Corhay J., and Radermecker M. Histamine-induced inhibition of neutrophil chemotaxis and T-lymphocyte proliferation in man. Allergy 47 6 (1992) 624-629
61. Peterson C., Skoog V., and Venge P. Human eosinophil cationic proteins (ECP and EPX) and their suppressive effects on lymphocyte proliferation. Immunobiology 171 1-2 (1986) 1-13
62. Ghio M., Contini P., Mazzei C., et al. Soluble HLA class I, HLA class II, and Fas ligand in blood components: a possible key to explain the immunomodulatory effects of allogeneic blood transfusions. Blood 93 5 (1999) 1770-1777
63. Ghio M., Ottonello L., Contini P., et al. Transforming growth factor-beta1 in supernatants from stored red blood cells inhibits neutrophil locomotion. Blood 102 3 (2003) 1100-1107
64. Anderson B., and Harken A. Multiple organ failure: inflammatory priming and activation sequences promote autologous tissue injury. The Journal of Trauma 30 12 Suppl (1990) S44-S49
65. Silliman C.C., Boshkov L., Mehdizadehkashi Z., et al. Transfusion-related acute lung injury: epidemiology and a prospective analysis of etiologic factors. Blood 101 2 (2003) 454-462
66. Popovsky M., and Moore S. Diagnostic and pathogenetic considerations in transfusion-related acute lung injury. Transfusion 25 6 (1985) 573-577
67. King K., Shirey R., Thoman S., et al. Universal leukoreduction decreases the incidence of febrile nonhemolytic transfusion reactions to RBCs. Transfusion 44 1 (2004) 1-4
68. Vamvakas E., and Blajchman M. Transfusion-related immunomodulation (TRIM): an update. Blood Reviews 21 6 (2007) 327-348
69. Van de Watering L., Hermans J., Houbiers J., et al. Beneficial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery: a randomized clinical trial. Circulation 97 6 (1998) 562-568
70. Bilgin Y., Van de Watering L., Eijsman L., et al. Double-blind, randomized controlled trial on the effect of leukocyte-depleted erythrocyte transfusions in cardiac valve surgery. Circulation 109 22 (2004) 2755-2760
71. Wallis J., Chapman C., Orr K., et al. Effect of WBC reduction of transfused RBCs on postoperative infection rates in cardiac surgery. Transfusion 42 9 (2002) 1127-1134
72. Blumberg N., Zhao H., Wang H., et al. The intention-to-treat principle in clinical trials and meta-analyses of leukoreduced blood transfusions in surgical patients. Transfusion 47 4 (2007) 573-581
73. Fergusson D., Khanna M.P., Tinmouth A., et al. Transfusion of leukoreduced red blood cells may decrease postoperative infections: two meta-analyses of randomized controlled trials. Canadian Journal of Anaesthesia 51 5 (2004) 417-424
74. Baron J., Gourdin M., Bertrand M., et al. The effect of universal leukodepletion of packed red blood cells on postoperative infections in high-risk patients undergoing abdominal aortic surgery. Anesthesia & Analgesia 94 3 (2002) 529-537
75. Hébert P.C., Fergusson D., Blajchman M., et al. Clinical outcomes following institution of the Canadian universal leukoreduction program for red blood cell transfusions. JAMA 289 15 (2003) 1941-1949
76. Fergusson D., Hébert P.C., Lee S., et al. Clinical outcomes following institution of universal leukoreduction of blood transfusions for premature infants. JAMA 289 15 (2003) 1950-1956
77. Llewelyn C., Taylor R., Todd A., et al. The effect of universal leukoreduction on postoperative infections and length of hospital stay in elective orthopedic and cardiac surgery. Transfusion 44 4 (2004) 489-500
78. Phelan H., Sperry J., and Friese R. Leukoreduction before red blood cell transfusion has no impact on mortality in trauma patients. The Journal of Surgical Research 138 1 (2007) 32-36
79. Taylor R.W., O'Brien J., Trottier S.J., et al. Red blood cell transfusions and nosocomial infections in critically ill patients. Critical Care Medicine 34 9 (2006) 2302-2308
80. Claridge J., Sawyer R., Schulman A., et al. Blood transfusions correlate with infections in trauma patients in a dose-dependent manner. American Surgeon 68 7 (2002) 566-572
81. Banbury M., Brizzio M., Rajeswaran J., et al. Transfusion increases the risk of postoperative infection after cardiovascular surgery. Journal of the American College of Surgeons 202 1 (2006) 131-138
82. Sreeram G., Welsby I., Sharma A., et al. Infectious complications after cardiac surgery: lack of association with fresh frozen plasma or platelet transfusions. Journal of Cardiothoracic and Vascular Anesthesia 19 4 (2005) 430-434
83. Shorr A.F., Jackson W.L., Kelly K.M., et al. Transfusion practice and blood stream infections in critically ill patients. Chest 127 5 (2005) 1722-1728
84. Hill G., Frawley W., Griffith K., et al. Allogeneic blood transfusion increases the risk of postoperative bacterial infection: a meta-analysis. The Journal of Trauma 54 5 (2003) 908-914
85. Stroncek D.F., and Rebulla P. Platelet transfusions. Lancet 370 9585 (2007) 427-438
86. Stanworth S., Brunskill S., Hyde C., et al. Is fresh frozen plasma clinically effective? A systematic review of randomized controlled trials. British Journal of Haematology 126 1 (2004) 139-152